AMendment 1 to LICENSE AND TRANSITION SERVICES AGREEMENTLicense and Transition Services Agreement • August 1st, 2023 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations
This AMENDMENT 1 to the License and Transition Services Agreement by and between Rigel Pharmaceuticals, Inc. (the “Company”) and Forma Therapeutics, Inc. (“Forma”) dated July 27, 2022 (the “Agreement”) is made and entered into this 22nd day of December 2022 (the “Amendment”).
